Insiders · Profile

Trimarchi Thomas

President and CFO at BridgeBio Pharma. Filing since 18 Aug 2025. CIK 0002030813

Company
Date
Role
Action
Shares
Amount
Of holding
18 May 2026
President and CFO
Sold on a plan
13,651
$888.42K
3.7%
17 Feb 2026
President and CFO
Sold on a plan
13,600
$1.02M
3.9%
17 Nov 2025
President and CFO
Sold on a plan
16,934
$1.13M
4.2%
21 Aug 2025
President and CFO
Sold at will
42,237
$2.09M
9.1%
18 Aug 2025
President and CFO
Sold on a plan
17,353
$871.72K
3.6%
5 decisions on file.